Grace Brescia
@Context Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$3.678BTotal holdings284
Assets growth rate32.28%Assets growth rate (2-Q avg)32.42%Continuous growth in asset value2 quarters
Portfolio positions
This chart displays the top 10 holdings in Context Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 284 positions.
Assets under management
The assets under management (AUM) of Context Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.678B in assets, with a quarterly growth rate of 32.28% and a 2-quarter average growth rate of 32.42%. The portfolio is managed by Grace Brescia, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
6047⤦Mirum Pharmaceuticals Inc
| 0.79% | $28.861M 19,645 shares@ $1469.13 avg price | Increased 1.75% |
6837⤦Opko Health Inc
| 0.73% | $26.725M 20,000 shares@ $1336.26 avg price | Increased 1.27% |
1564⤦Century Alum Co
| 0.72% | $26.128M 23,592 shares@ $1107.5 avg price | Increased 30.41% |
0043⤦Accolade Inc
| 0.71% | $25.822M 27,991 shares@ $922.5 avg price | |
0427⤦Array Technologies Inc
| 0.71% | $25.806M 34,584 shares@ $746.19 avg price | Increased 26.45% |
9168⤦Upstart Holdings Inc
| 0.71% | $25.803M 23,500 shares@ $1098.0 avg price | New Position |
6700⤦Novavax Inc
| 0.7% | $25.637M 20,288 shares@ $1263.65 avg price | Increased 25.33% |
4633⤦Ironwood Pharmaceuticals Inc
| 0.69% | $25.12M 28,250 shares@ $889.21 avg price | New Position |
2289⤦Artivion Inc
| 0.68% | $24.752M 19,900 shares@ $1243.82 avg price | |
5494⤦Lucid Group Inc
| 0.68% | $24.73M 36,535 shares@ $676.88 avg price | Increased 15.4% |